A worthwhile overview in npj Digital Medicine about the still young genre of Digital Therapeutics (DTx), which are classified as regulated medical devices worldwide, but whose definition depends on the regulatory decisions in the individual countries. Researchers are pushing for the development of an internationally harmonized regulatory model. Recent DTx studies show that DTx are not only being targeted for chronic and mental illnesses, but also in clinical settings for individual diseases.
LINK